Category Press Releases

PolyCera® Secures Phase Two of Large-Scale Lithium Extraction Initiative in Tibet, China

PolyCera® Secures Phase Two of Large-Scale Lithium Extraction Initiative in Tibet, China PolyCera®, a brand under PSP.US, a renowned global leader in next-generation membrane technology, has proudly announced its selection for the second phase of the Salt Lake Lithium Extraction…

Read MorePolyCera® Secures Phase Two of Large-Scale Lithium Extraction Initiative in Tibet, China

Perma-Pipe International Holdings, Inc. Announces CEO Retirement and Names Saleh Sagr as New President

Perma-Pipe International Holdings,has announced that Chief Executive Officer (CEO) David Mansfield will retire on or before November 8, 2025. To ensure a seamless leadership transition, the company has appointed Saleh Sagr as President, effective immediately. Mr. Mansfield will continue in…

Read MorePerma-Pipe International Holdings, Inc. Announces CEO Retirement and Names Saleh Sagr as New President

Merck and Zebra Technologies Partner for Safety and Traceability Solutions

Merck and Zebra Technologies Partner for Safety and Traceability Solutions Merck, a leading science and technology company, has joined forces with Zebra Technologies Corporation, a global leader in digitizing and automating frontline workflows, to co-create innovative solutions that tackle pressing…

Read MoreMerck and Zebra Technologies Partner for Safety and Traceability Solutions
Two Prestigious Awards Recognized at Asia-Pacific Biopharma Excellence Awards 2025 for Avantor®

Two Prestigious Awards Recognized at Asia-Pacific Biopharma Excellence Awards 2025 for Avantor®

Two Prestigious Awards Recognized at Asia-Pacific Biopharma Excellence Awards 2025 for Avantor® Avantor Inc., a leading global provider of mission-critical products and services for the life sciences and advanced technologies industries, was recently honored with two prestigious awards at the…

Read MoreTwo Prestigious Awards Recognized at Asia-Pacific Biopharma Excellence Awards 2025 for Avantor®
Puhe BioPharma and Bayer Sign Global License Deal for Phase I PRMT5 Inhibitor

Puhe BioPharma and Bayer Sign Global License Deal for Phase I PRMT5 Inhibitor

Bayer and Puhe BioPharma Enter Global License Agreement for PRMT5 Inhibitor Bayer and Suzhou Puhe BioPharma Co., Ltd., a clinical-stage biotechnology company, have entered into a global licensing agreement to develop, manufacture, and commercialize an oral, small-molecule PRMT5 inhibitor, BAY…

Read MorePuhe BioPharma and Bayer Sign Global License Deal for Phase I PRMT5 Inhibitor